Does BIMEKIZUMAB Cause Off label use? 160 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 160 reports of Off label use have been filed in association with BIMEKIZUMAB (Bimzelx). This represents 6.5% of all adverse event reports for BIMEKIZUMAB.
160
Reports of Off label use with BIMEKIZUMAB
6.5%
of all BIMEKIZUMAB reports
1
Deaths
36
Hospitalizations
How Dangerous Is Off label use From BIMEKIZUMAB?
Of the 160 reports, 1 (0.6%) resulted in death, 36 (22.5%) required hospitalization, and 2 (1.3%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIMEKIZUMAB. However, 160 reports have been filed with the FAERS database.
What Other Side Effects Does BIMEKIZUMAB Cause?
Psoriatic arthropathy (615)
Psoriasis (400)
Drug ineffective (293)
Inappropriate schedule of product administration (238)
Injection site pain (225)
Product dose omission issue (163)
Oral candidiasis (146)
Fatigue (138)
Therapy interrupted (138)
Pneumonia (118)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which BIMEKIZUMAB Alternatives Have Lower Off label use Risk?
BIMEKIZUMAB vs BIMEKIZUMAB-BKZX
BIMEKIZUMAB vs BINIMETINIB
BIMEKIZUMAB vs BIOFLAVONOIDS
BIMEKIZUMAB vs BIOTIN
BIMEKIZUMAB vs BIPERIDEN